Summary
A double-antibody radioimmunoassay method, using synthetic human connecting peptide as an immunizing antigen and standard, was evaluated for clinical assay of blood and urine samples. Normal fasting blood connecting peptide immunoreacivity (CPR) was 2.45±0.96 ng/ml, increasing promptly after a 50 g oral glucose load, but somewhat slower than insulin. Molar concentration of CPR exceeded that of insulin. CPR responses to glucose were subnormal in diabetics, very low in juvenile-type cases, and often poor in patients on insulin treatment. Fasting CPR levels were elevated in patients on corticosteroid treatment and with uraemia. A patient with insulin “auto-antibod” had high serum CPR. A considerable amount of CPR appeared in urine. Normal daily excretion of CPR was 1.52±0.55 μg/kg or 55.1±18.2 ng/mg creatinine. Urine CPR was very low in juvenile-type diabetics, and elevated in patients on corticosteroid treatment. The results confirm that blood and urine CPR are useful measures of the endocrine pancreatic function.
Article PDF
Similar content being viewed by others
References
Steiner, D. F., Oyer, P. E.: The biosynthesis of insulin and probable precursor of insulin by a human islet cell adenoma. Proc. nat. Acad. Sci. (Wash.)57, 473–480 (1967)
Steiner, D. F., Clark, J. L., Nolan, C., Rubenstein, A. H., Margoliash, E., Aten, B., Oyer, P. E.: Proinsulin and the biosynthesis of insulin. Recent Progr. Hormone Res.25, 207–282 (1969)
Rubenstein, A. H., Block, M. B., Starr, J., Melani, F., Steiner, D. F.: Proinsulin and C-peptide in blood. Diabetes21 (Suppl. 2), 661–672 (1972)
Melani, F., Rubenstein, A. H., Oyer, P. E., Steiner, D. F.: Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc. nat. Acad. Sci. (Wash.)67, 148–155 (1970)
Heding, L. G., Larsen, U. D., Markussen, J., Jørgensen, K. H., Hallund, O.: Radioimmunoassays for human, pork and ox C-peptides and related substances. Horm. Metab. Res.5 (Suppl.), 40–44 (1974)
Yanaihara, N., Hashimoto, T., Yanaihara, C., Sakagami, M.: Synthesis of human connecting peptide derivatives and their immunological properties. Biochem. biophys. Res. Commun.59, 1124–1130 (1974)
Kaneko, T., Oka, H., Munemura, M., Oda., Yamashita, K., Suzuki, S., Yanaihara, N., Hashimoto, T., Yanaihara, C.: Radioimmunoassay of human proinsulin, C-peptide using synthetic human connecting peptide. Endocr. jap.21, 141–145 (1974)
Kanazawa, Y., Kuzuya, T., Ide, T., Kosaka, K.: Plasma insulin responses to glucose in femoral, hepatic, and pancreatic veins in dogs. Amer. J. Physiol.211, 442–448 (1966)
Technicon Autoanalyzer II, clinical method No. 02, March 1972
Bosnes, R. W., Taussky, H. H.: On the colorimetric determination of creatinine by the Jaffe reaction. J. biol. Chem.158, 581–591 (1945)
Kawazu, S., Kanazawa, Y., Kajinuma, H., Miki, E., Kuzuya, T., Kosaka, K.: Demonstration of anti-“a-component” antibody-A possible means to differentiate patients with auto-antibodies to endogenous insulin from insulin-treated patients. Diabetologia11, 169–173 (1975)
Rubenstein, A. H., Clark, J. L., Melani, F., Steiner, D. F.: Secretion of proinsulin C-peptide by pancreatic B-cells and its circulation in blood. Nature (Lond.)224, 697–699 (1969)
Block, M. B., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients. Diabetes21, 1013–1026 (1972)
Horwitz, D. L., Starr, J. I., Mako, M. E., Blackard, W. G., Rubenstein, A. H.: Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J. clin. Invest.55, 1278–1283 (1975)
Kanazawa, Y., Kawazu, S., Kajinuma, H., Kosaka, K.: Secretion of insulin and C-peptide from the monolayer culture of an insulinoma (in Japanese). J. Japan Diabetic Society18, 716 (1975)
Heding, L. G., Rasmussen, S. M.: Human C-peptide in normal and diabetic subjects. Diabetologia11, 201–206 (1975)
Horwitz, D. L., Starr, J. I., Rubenstein, A. H., Steiner, D. F.: Serum connecting peptide — An indicator of beta cell secretory function. Diabetes22 (Suppl. 1), 298 (1973)
Munemura, M., Kaneko, T., Oka, H., Yamashita, K., Suzuki, S., Oda, T., Yanaihara, N., Yanaihara, C.: Disappearance from blood of synthetic human C-peptide (in Japanese). Folia endocr. jap.50, 1410 (1974)
Block, M. B., Rosenfield, R. L., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Sequential changes in beta-cell function in insulin treated diabetic patients assessed by C-peptide immunoreactivity. New Engl. J. Med.288, 1144–1148 (1973)
Kaneko, T., Munemura, M., Oka, H., Oda, T., Suzuki, H., Yasuda, H., Yanaihara, N., Nakagawa, S., Makabe, K.: Demonstration of C-peptide immunoreactivity in various body fluids and clinical evaluation of the determination of urinary C-peptide immunoreactivity. Endocr. jap.22, 207–212 (1975)
McCullagh, E., McCullagh, P., Cook, J.R., Shirey, E. K.: Diabetes following total pancreatectomy. Diabetes7, 298–307 (1958)
Katz, A. I., Rubenstein, A. H.: Metabolism of proinsulin, insulin and C-peptide in the rat. J. clin. Invest.52, 1113–1121 (1973)
Elgee, N. J., Williams, R. H., Lee, N. D.: Distribution and degradation studies with insulin-I131. J. clin. Invest.33, 1252–1260 (1954)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuzuya, T., Matsuda, A., Saito, T. et al. Human C-peptide immunoreactivity (CPR) in blood and urine — Evaluation of a radioimmunoassay method and its clinical applications. Diabetologia 12, 511–518 (1976). https://doi.org/10.1007/BF01219516
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219516